Globeflex Capital »

Fennec Pharmaceuticals shares owned by Globeflex Capital

Quarter-by-quarter ownership of Fennec Pharmaceuticals (FENC) shares owned by Globeflex Capital from 13F filings

Historical chart of Globeflex Capital investment in Fennec Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Fennec Pharmaceuticals held by Globeflex Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fennec Pharmaceuticals by Globeflex Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $113k 18k 6.15

More positions owned by Globeflex Capital

Intercorp Financial Services (IFS)
Phibro Animal Health Corporati*on Cmn Class A (PAHC)
Blue Bird Corp (BLBD)
Exelixis (EXEL)
Catalyst Pharmaceutical Partners (CPRX)
Cirrus Logic (CRUS)
Ypf Sa (YPF)
Allegheny Technologies Incorporated (ATI)
Copa Holdings Sa-class A (CPA)
EnerSys (ENS)
Marex Group (MRX)
Credicorp (BAP)
ESCO Technologies (ESE)
MKS Instruments (MKSI)
Costamare (CMRE)

View all positions for Globeflex Capital

Top funds holding Fennec Pharmaceuticals

Southpoint Capital Advisors
Rosalind Advisors
Solas Capital Management
AIGH Capital Management
BlackRock
Vanguard Group
Vanguard Capital Management
AWM Investment Company
Geode Capital Management
State Street Corporation
Morgan Stanley
Apis Capital Advisors
Vanguard Portfolio Management
Citadel Advisors
Marshall Wace

View all funds holding Fennec Pharmaceuticals